NEW YORK, NY / ACCESSWIRE / August 30, 2019 /

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Bancorp of New Jersey, Inc. (NYSE American:BKJ) (“the Company”) regarding its acquisition by ConnectOne Bancorp, Inc. Under the terms of the proposed transaction, each share of the Company’s common stock will be converted into the right to receive either $16.25 in cash per share, 0.78 shares of ConnectOne common stock, or a combination of both. Click here for more information: https://www.monteverdelaw.com/case/bancorp-new-jersey-inc. It is free and there is no cost or obligation to you.
LegacyTexas Financial Group, Inc. (NASDAQ:LTXB) (“Legacy”) related to its merger agreement with Prosperity Bancshares, Inc. (“Prosperity”). Under the terms of the agreement, each share of Legacy common stock will be converted into the right to receive: (i) 0.5280 shares of Prosperity common stock; and (ii) $6.28 in cash. Click here for more information: https://www.monteverdelaw.com/case/legacytexas-financial-group-inc. It is free and there is no cost or obligation to you.
Old Line Bancshares, Inc. (NASDAQ:OLBK) (“Old Line”) regarding its sale to WesBanco, Inc. (“WesBanco”). Under the terms of the agreement, each share of Old Line common stock will be converted into the right to receive 0.7844 shares of WesBanco common stock per share of Old Line common stock owned. Click here for more information: https://www.monteverdelaw.com/case/old-line-bancshares-inc. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC

The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 558072

LOS ANGELES, CA / ACCESSWIRE / August 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CannTrust Holdings Inc. (“CannTrust” or “the Company”) (NYSE:CTST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CannTrust announced on July 8, 2019, that its greenhouse facility located in Ontario, Canada, was audited by Health Canada, which rated it “non-compliant.” Health Canada placed a hold on 5,200 kilograms of dried cannabis allegedly harvested from five unlicensed rooms. It will hold this cannabis until the Company is in compliance with regulations. CannTrust also announced it would hold another 7,500 kilograms of dried cannabis that it says was also produced in unlicensed rooms. Based on this news, shares of CannTrust fell by more than 21% in intraday trading on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 558056

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Eagle Bancorp, Inc. (NASDAQ:EGBN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/eagle-bancorp-inc-loss-submission-form?prid=3284&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: March 2, 2015 to July 17, 2019

Allegations against EGBN include that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

National General Holdings Corp. (NASDAQ:NGHC)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/national-general-holdings-corp-loss-submission-form?prid=3284&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: August 6, 2015 to August 9, 2017

Allegations against NGHC include that: (a) National General was perpetrating a massive forced-placed CPI scheme to fraudulently saddle its own customers with unwanted and unneeded automobile insurance policies that it had underwritten; (b) National General’s illicit conduct in foisting unwanted and unneeded automobile insurance on its customers had resulted in some of the victims being declared delinquent, suffering adverse impacts to their creditworthiness, and/or having their cars improperly repossessed; (c) National General was exposed to an extreme risk of regulatory scrutiny, legal risks, and reputational harm as a result of its participation in the forced placed CPI scheme; (d) the Company had failed to maintain effective internal controls over its financial reporting, including by failing to maintain formal documentation sufficient to reasonably ensure the accuracy of internal reporting and accounting procedures across much of its business, including with respect to insurance policy premiums; (e) the Company’s reported quarterly revenues and policy premiums were in part the product of a fraudulent forced-placed insurance scheme and were therefore artificially inflated and unsustainable; and (f) National General had in fact lost substantial business with Wells Fargo because Wells Fargo had terminated the forced-placed CPI scheme after concluding that it posed excessive reputational risk and legal exposure.

Valaris plc (NYSE:VAL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/valaris-plc-loss-submission-form?prid=3284&wire=1
Lead Plaintiff Deadline: October 21, 2019
Class Period: April 11, 2019 to July 31, 2019

Allegations against VAL include that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (iii) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 558071

CEDARHURST, NY / ACCESSWIRE / August 30, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

Realogy Holdings Corp. (NYSE:RLGY)

Investors Affected : February 24, 2017 – May 22, 2019

A class action has commenced on behalf of certain shareholders in Realogy Holdings Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Realogy was engaged in anticompetitive behavior by requiring property sellers to pay the commissions of a buyer’s broker at an inflated rate; (2) Realogy’s anticompetitive actions would prompt the U.S. Department of Justice (“DOJ”) to open an antitrust investigation into the real estate industry’s practices regarding brokers’ commissions; and (3) as a result, Defendants’ statements about the Realogy’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/realogy-holdings-corp-loss-submission-form/?id=3283&from=1

Pluralsight, Inc. (NASDAQGS:PS)

Investors Affected : August 2, 2018 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Pluralsight, Inc. According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering (“SPO”) that it was behind schedule onboarding new sales representatives, which was hurting the Company’s sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

Shareholders may find more information at https://kclasslaw.com/securities/pluralsight-inc-loss-submission-form/?id=3283&from=1

International Flavors & Fragrances Inc. (NYSE:IFF)

Investors Affected : May 7, 2018 – August 5, 2019

A class action has commenced on behalf of certain shareholders in International Flavors & Fragrances Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/international-flavors-fragrances-inc-loss-submission-form/?id=3283&from=1

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967

SOURCE: Kuznicki Law PLLC

ReleaseID: 558070

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced the appointment of Gregory S. Moss, Esq. as Executive Vice President, General Counsel and Corporate Secretary. Mr. Moss will also serve as the Company’s Chief Compliance Officer.

“Greg has been a key part of Kadmon’s senior management team for many years, including during our IPO. He has advised our Board of Directors and management on corporate governance and compliance matters and has provided astute counsel in connection with a number of major corporate activities, including the 2015 spinoff of our gene therapy platform into MeiraGTx,” said Harlan W. Waksal, M.D., President and CEO of Kadmon. “Greg’s deep experience with Kadmon makes him a natural fit as general counsel. On behalf of the Company and our Board of Directors, I welcome Greg into his new role.”

Mr. Moss joined Kadmon in 2012 and from 2015 until August 2019, served as Senior Vice President, Deputy General Counsel. Mr. Moss previously served as Acting General Counsel and Compliance Officer of MeiraGTx Limited (now MeiraGTx Holdings plc) (Nasdaq: MGTX) and as a member of the Board of Directors of MeiraGTx until June 2019. Prior to joining Kadmon, Mr. Moss worked as a solicitor in the Corporate Risk practice group of Gadens Lawyers (now Dentons Australia) and at a boutique legal practice and hedge fund in New York City. Mr. Moss holds a Bachelor of Arts and Bachelor of Laws (BA/LLB) from Macquarie University, Sydney, Australia.

The Company also announced that Steven N. Gordon, Esq. notified the Company of his resignation from his role as Executive Vice President, General Counsel, Chief Administrative, Compliance and Legal Officer, and Corporate Secretary of the Company, effective immediately, in order to pursue other opportunities.

About Kadmon

Kadmon is a biopharmaceutical company developing innovative products for significant unmet medical needs. Our product pipeline is focused on inflammatory and fibrotic diseases as well as immuno-oncology.

Forward Looking Statements

This press release contains forward-looking statements. Such statements may be preceded by the words “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We believe that these factors include, but are not limited to, (i) the initiation, timing, progress and results of our preclinical studies and clinical trials, and our research and development programs; (ii) our ability to advance product candidates into, and successfully complete, clinical trials; (iii) our reliance on the success of our product candidates; (iv) the timing or likelihood of regulatory filings and approvals; (v) our ability to expand our sales and marketing capabilities; (vi) the commercialization of our product candidates, if approved; (vii) the pricing and reimbursement of our product candidates, if approved; (viii) the implementation of our business model, strategic plans for our business, product candidates and technology; (ix) the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology; (x) our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties; (xi) costs associated with defending intellectual property infringement, product liability and other claims; (xii) regulatory developments in the United States, Europe and other jurisdictions; (xiii) estimates of our expenses, future revenues, capital requirements and our needs for additional financing; (xiv) the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements; (xv) our ability to maintain and establish collaborations or obtain additional grant funding; (xvi) the rate and degree of market acceptance of our product candidates; (xvii) developments relating to our competitors and our industry, including competing therapies; (xviii) our ability to effectively manage our anticipated growth; (xix) our ability to attract and retain qualified employees and key personnel; (xx) our ability to achieve cost savings and other benefits from our efforts to streamline our operations and to not harm our business with such efforts; (xxi) the use of proceeds from our recent public offerings; (xxii) the potential benefits of any of our product candidates being granted orphan drug designation; (xxiii) the future trading price of the shares of our common stock and impact of securities analysts’ reports on these prices; and/or (xxiv) other risks and uncertainties. More detailed information about Kadmon and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 5, 2019. Investors and security holders are urged to read these documents free of charge on the SEC’s website at www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Contact Information

Ellen Cavaleri, Investor Relations
646.490.2989
ellen.cavaleri@kadmon.com

SOURCE: Kadmon Holdings, Inc.

ReleaseID: 558013

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Eurobank Ergasias SA (OTCPINK: EGFEY) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 30, 2019 at 6:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visithttps://www.investornetwork.com/company/C-60C95EF5284DF

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 557929

HOUSTON, TX / ACCESSWIRE / August 30, 2019 / Students, faculty and staff members at Lone Star College-University Park joined together this week to celebrate the beginning of the fall 2019 semester by kicking off ROAR Week.

From ice cream socials to meet-and-greets with faculty, ROAR Week is a LSC-University Park tradition that offers a blend of entertainment and informational resources to new and returning students.

“ROAR Week is an exciting tradition at LSC-University Park as we open each semester,” said Dr. Shah Ardalan, LSC-University Park president. “It’s a great opportunity for our students to learn about student groups, volunteer opportunities and class options all in one place. We want to show our students that we appreciate them and are committed to helping them succeed.”

During the week, students network with their peers, faculty and staff. Highlights of the week include: “Donuts with Deans,” “Coffee Talk with Your Professor,” “Waffle Bar Wednesday,” “Ice Cream Social” and “Pizza Party.” Other activities like “Spin Art,” “Plant Your Own Lucky Bamboo” and “Trivia Game Show” also help students unwind after a full day of class. ROAR Week events are free and open to enrolled LSC-University Park students.

ROAR Week is just one of the many opportunities students have to discover LSC-University Park. The college offers an open learning environment with convenient options in face-to-face, online and hybrid delivery modes. LSC-University Park also offers over 70 programs leading to industry certifications and associate degrees in high-demand disciplines and careers. In 2018, the college launched its innovative GradUP initiative, which aims to increase the three-year student graduation rate by 300% in three years.

Classes start throughout the year at LSC-University Park. To learn about Late Start registration and how to join the LSC-University Park family, go to LoneStar.edu/UP-LateStart.

Established in 2012, LSC-University Park has been recognized as one of the fastest growing and most innovative institutions of higher education in the country. Under its founding president, Dr. Shah Ardalan, LSC-University Park is committed to the community’s prosperity and upward mobility through student success. The college’s competent and compassionate faculty and staff provide students with holistic and immersive education and training in disciplines and industries that meet current and future workforce needs. Standout college facilities include the Center for Science & Innovation, the Energy & Manufacturing Institute, the Learning Innovation Labs and the Geology Rock Wall. For more information about LSC-University Park, please visit LoneStar.edu/UP or call 281.290.2600.

Lone Star College offers high-quality, low-cost academic transfer and career training education to 99,000 students each semester. LSC is training tomorrow’s workforce today and redefining the community college experience to support student success. Stephen C. Head, Ph.D., serves as chancellor of LSC, the largest institution of higher education in the Houston area with an annual economic impact of nearly $3 billion. LSC consists of seven colleges, eight centers, two university centers, Lone Star Corporate College and LSC-Online. To learn more, visit LoneStar.edu.

New Beginnings. Students at Lone Star College-University Park take part in different ROAR Week events.

Media Contact:

Kimberley Baker
Interim Executive Director
College Relations
281.401.5315 (O)
Kimberley.Baker@LoneStar.edu

Elizabeth Hale
Writer
College Relations
281.290.3690
Elizabeth.Hale@LoneStar.edu

SOURCE: Lone Star College-University Park

ReleaseID: 558037

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Omnicell, Inc. (NASDAQGS:OMCL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/omnicell-inc-loss-submission-form?prid=3282&wire=1
Lead Plaintiff Deadline: September 16, 2019
Class Period: October 25, 2018 to July 11, 2019

Allegations against OMCL include that: (1) the Company recognized revenue for certain transactions before fulfilling its performance obligations; (2) the Company engaged in improper accounting practices to meet revenue targets; (3) the Company experienced weaker demand for new product lines than it had previously projected; (4) as a result, the Company would be required to write-off certain inventory; (5) the Company misclassified certain expenses as capitalized expenditures; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Carbonite, Inc. (NASDAQGM:CARB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/carbonite-inc-loss-submission-form?prid=3282&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: February 7, 2019 to July 25, 2019

Allegations against CARB include that: (i) Carbonite’s Server Backup VM Edition was of poor quality and technologically flawed; (ii) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (iii) the poor quality and technological flaws of the Server Backup VM Edition was acting as a “disruptive” factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (iv) as a result of the foregoing, Carbonite lacked any reasonable basis for issuing its positive projections and financial forecasts.

Granite Construction Incorporated (NYSE:GVA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/granite-construction-incorporated-loss-submission-form?prid=3282&wire=1
Lead Plaintiff Deadline: October 15, 2019
Class Period: October 26, 2018 to August 1, 2019

Allegations against GVA include that: (1) the Company had assumed certain risks in connection with its heavy civil joint venture projects bid between 2012 and 2014; (2) there was an “untenable” imbalance of risk sharing between the Company and the joint venture project owners; (3) as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 558063

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Reckitt Benckiser Group plc (OTC PINK:RBGLY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/reckitt-benckiser-group-plc-loss-submission-form?prid=3281&wire=1.
Lead Plaintiff Deadline: September 13, 2019
Class Period: On behalf of all purchasers of Reckitt American Depositary Shares (“ADSs”) from July 28, 2014 through April 9, 2019

Allegations against RBGLY include that: (a) defendants had engaged in a scheme to artificially inflate the sales of Suboxone Film by more than $3 billion by falsely touting the drug’s purportedly superior efficacy and safety as compared to tablets; (b) contrary to defendants’ public statements, the FDA and internal Company documents had concluded that Suboxone Film posed a potentially greater risk of abuse and child endangerment than other available treatments; (c) defendants had fabricated a safety scare involving Suboxone Tablets in order to unlawfully delay and prevent generic competition; (d) defendants had engaged in a massive marketing campaign that had misrepresented the purported benefits of Suboxone Film as compared to Suboxone Tablets to doctors, healthcare providers, government regulators and investors; (e) defendants had encouraged Suboxone sales through medical providers that they knew were overprescribing the drug, facilitating the drug’s abuse and/or prescribing it in a careless and clinically unwarranted manner, often to hundreds of individuals at a time; (f) as a result of (a)-(e) above, Reckitt’s revenues, net income an d earnings were artificially inflated and the product of illicit business practices; and (g) as a result of (a)-(f) above, Reckitt and Reckitt Pharma were exposed to extraordinary undisclosed legal and reputational risks that could result in billions of dollars in fines, lost business and legal judgments or other monetary penalties.

Netflix, Inc. (NASDAQGS:NFLX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/netflix-inc-loss-submission-form?prid=3281&wire=1.
Lead Plaintiff Deadline: September 20, 2019
Class Period: April 17, 2019 to July 17, 2019

Allegations against NFLX include that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Cardinal Health, Inc. (NYSE:CAH)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cardinal-health-inc-loss-submission-form?prid=3281&wire=1.
Lead Plaintiff Deadline: September 30, 2019
Class Period: March 2, 2015 to May 2, 2018

Allegations against CAH include that: 1) following Cardinal’s acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis’s performance were never implemented across Cordis; 2) Cordis’s antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; 3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; 4) the Company materially overstated Cordis’s inventory balances; 5) Cordis was not “performing well” and its integration was not “on track,” “going incredibly well” or “largely on plan”; and 6) to correct Cordis’s deficiencies, the Company would have to make substantial investments in Cordis’s IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 558062

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Up Fintech Holding Limited (Fintech” or the “Company”) (NASDAQ:TIGR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Fintech and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On or about March 20, 2019, Fintech conducted its initial public offering (“IPO”), selling 13 million American depositary receipts priced at $8.00 a share and raising $104,000,000 in new capital. Since the IPO, Fintech’s share price has fallen sharply, closing at a low of $4.00 per share on August 2, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 558060